Pages that link to "Q44006487"
Jump to navigation
Jump to search
The following pages link to Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs (Q44006487):
Displaying 16 items.
- Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection (Q21134914) (← links)
- Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer (Q28264693) (← links)
- Generalized monotone incremental forward stagewise method for modeling count data: application predicting micronuclei frequency. (Q30953181) (← links)
- Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets (Q33741864) (← links)
- Prediction of heterogeneous differential genes by detecting outliers to a Gaussian tight cluster (Q34622362) (← links)
- Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ (Q35051566) (← links)
- Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. (Q35203556) (← links)
- Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer (Q35603635) (← links)
- Noncanonical TGF-β Signaling During Mammary Tumorigenesis (Q37044600) (← links)
- Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study (Q37709430) (← links)
- Hide and seek: tell-tale signs of breast cancer lurking in the blood. (Q38056383) (← links)
- Meta-analysis of the differentially expressed breast cancer-related microRNA expression profiles (Q38476055) (← links)
- NanoString-based breast cancer risk prediction for women with sclerosing adenosis (Q38629398) (← links)
- Gene expression information improves reliability of receptor status in breast cancer patients (Q43654815) (← links)
- Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients (Q85654277) (← links)
- Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status (Q87401555) (← links)